
Surgical Science Sweden Ab (publ)
(OTC) SUSRF
Surgical Science Sweden Ab (publ) Financials at a Glance
Market Cap
$204.10M
Revenue (TTM)
SEK 976.46M
Net Income (TTM)
SEK 52.12M
EPS (TTM)
$0.11
P/E Ratio
36.20
Dividend
$0.00
Beta (Volatility)
-0.05 (Low)
Dividend
$0.00
Beta (Volatility)
-0.05 (Low)
Price
$4.00
Volume
200
Open
$4.00
Price
$4.00
Volume
200
Open
$4.00
Previous Close
$4.00
Daily Range
$4.00 - $4.00
52-Week Range
$2.84 - $16.33
Dividend
$0.00
Beta (Volatility)
-0.05 (Low)
Price
$4.00
Volume
200
Open
$4.00
Previous Close
$4.00
Daily Range
$4.00 - $4.00
52-Week Range
$2.84 - $16.33
SUSRF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Surgical Science Sweden Ab (publ)
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
317
CEO
Tom Englund
Website
www.surgical-science.comHeadquarters
Gothenburg, 412 50, SE
SUSRF Financials
Key Financial Metrics (TTM)
Gross Margin
63%
Operating Margin
8%
Net Income Margin
5%
Return on Equity
1%
Return on Capital
2%
Return on Assets
1%
Earnings Yield
2.76%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$204.10M
Shares Outstanding
51.03M
Volume
200
Avg. Volume
7
Financials (TTM)
Gross Profit
SEK 575.46M
Operating Income
SEK 108.70M
EBITDA
SEK 191.86M
Operating Cash Flow
SEK 79.59M
Capital Expenditure
-SEK 11.65M
Free Cash Flow
SEK 67.95M
Cash & ST Invst.
SEK 614.88M
Total Debt
SEK 1.62M
Surgical Science Sweden Ab (publ) Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
SEK 235.48M
-6.1%
Gross Profit
SEK 154.97M
-10.2%
Gross Margin
65.81%
N/A
Market Cap
$204.10M
N/A
Market Cap/Employee
$744.91K
N/A
Employees
274
N/A
Net Income
SEK 18.63M
-44.0%
EBITDA
SEK 22.87M
-4.4%
Quarterly Fundamentals
Net Cash
SEK 665.58M
+8.9%
Accounts Receivable
SEK 311.36M
+0.9%
Inventory
SEK 207.50M
+10.4%
Long Term Debt
SEK 0.00
N/A
Short Term Debt
SEK 2.15M
+30.5%
Return on Assets
1.09%
N/A
Return on Invested Capital
1.65%
N/A
Free Cash Flow
SEK 47.35M
+402.5%
Operating Cash Flow
SEK 65.31M
+1417.2%